NASDAQ:BNTX

Biontech Se Sponsored Adr Stock News

etoro logo Buy BNTX
*Your capital is at risk
$90.58
-2.27 (-2.44%)
At Close: Jul 31, 2026
Freestone Capital Holdings LLC acquired a new stake in BioNTech SE Sponsored ADR (NASDAQ: BNTX) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Excha
BioNTech today announced positive results from the primary analysis of a Phase 2 cohort evaluating trastuzumab pamirtecan in HER2+ endometrial cancer.
Vaccine makers Pfizer ‌and BioNTech have halted recruitment for a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment ​in the trials had been too
The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast.
MAINZ, Germany, March 24, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data from its diversified portfolio in the field of lung cancer at the European Lung C
The first severe case of the virus has been detected in New York.
BioNTech (BNTX) reported upbeat Q4 results and FY26 sales guidance below estimates. Shares gained 7.7% on Wednesday. Analysts have mixed opinions.
On March 10, 2026, Oracle outperformed in after-hours trading and oil prices fell in a volatile, energy-driven session.
BioNTech SE (BNTX) Q4 2025 Earnings Call Transcript
Stock News U.S. pump prices jump on war-driven supply shock: Average U.S. gasoline rose to about $3.54/gal, the highest since mid‑2024, as the U.S.–Iran con
The company guided 2026 total revenue to roughly $2.2–$2.5 billion, below Street expectations, stating that Covid will be a smaller contributor going forward and growth will depend increasingly on t
SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of BioNTech SE (NASDAQ: BNTX). The investigation focuses on BioNTech's execu
BioNTech (NASDAQ: BNTX) swung to a Q4 loss and guided for “lower-than-expected” full-year revenue on Tuesday. But the stock crashed more than 20%, mostly because its cofounders, Ugur Sahin (CEO) a
BioNTech SE (NASDAQ:BNTX) co-founders Ugur Sahin and Özlem Türeci plan to launch a new independent biotech company focused on next-generation mRNA technologies, the German vaccine developer said on

Why BioNTech Stock Is Getting Crushed Today

11:47am, Tuesday, 10'th Mar 2026
German biopharma outfit BioNTech SE reported lackluster fiscal Q4 results on Tuesday. Guidance for the year now underway is just as disappointing.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE